Verdict: Side-by-side breakdown using the Bull Rankings model. DX scored 75.0, AGNC scored 71.0 — DX leads.
Compare another set
DX
Dynex Capital, Inc.
REIT - Mortgage · Financial strength
76.9Fin
$10.85 · $2.7B
fundamentals as of
Strength gap
1.6
DX leads
AGNC
AGNC Investment Corp.
REIT - Mortgage · Financial strength
75.3Fin
$8.61 · $10.2B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
Fastest growthDX+147.4%
Strongest balance sheetDX7.13
Side by side · every name on one set of axes
Fundamentals, head-to-head
DX
AGNC
18.8%C+
Yield
16.6%C+
+147.4%A
Rev
+84.7%A
7.13D
D/E
7.17D
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
DXDynex Capital, Inc.
REIT - Mortgage · $10.85 · beta 0.96
Why now
REIT - Mortgage · market cap $2.7b. Down 27% from 52-week high of $14.93 — deep drawdown territory. Revenue growing +147% — in hypergrowth territory. PEG 0.71 — paying under fair value for the growth rate. 5 sell-side analysts rate this a Buy with a mean 1-yr target of $13.75 (implying +27% upside).
Moat
Net margin 87% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 18% is above 15% — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
D/E 7.13 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Dividend payout 71% of earnings on a 18.8% yield — distribution coverage is thin; one earnings stumble could force a dividend cut.
AGNCAGNC Investment Corp.
REIT - Mortgage · $8.61 · beta 1.34
Why now
REIT - Mortgage · market cap $10.2b. Down 29% from 52-week high of $12.19 — deep drawdown territory. Revenue growing +85% — in hypergrowth territory. 9 sell-side analysts rate this a Hold with a mean 1-yr target of $10.61 (implying +23% upside).
Moat
Net margin 94% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 20% is above 15% — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
D/E 7.17 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Dividend payout 73% of earnings on a 16.6% yield — distribution coverage is thin; one earnings stumble could force a dividend cut.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Common questions
Is DX or AGNC the better stock?
DX scores higher: DX 75.0, AGNC 71.0 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
How are DX and AGNC scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.